文献
J-GLOBAL ID:202202278926921679
整理番号:22A0834508
CheckMate 214試験における腎切除および評価可能な原発性腎臓腫瘍を伴う患者における第一選択ニボルマブ+イピリムマブ対スニチニブ【JST・京大機械翻訳】
First-line Nivolumab plus Ipilimumab Versus Sunitinib in Patients Without Nephrectomy and With an Evaluable Primary Renal Tumor in the CheckMate 214 Trial
著者 (22件):
Albiges Laurence
(Department of Cancer Medicine, Gustave Roussy, Villejuif, France)
,
Tannir Nizar M.
(Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Burotto Mauricio
(Bradford Hill Clinical Research Center, Santiago, Chile)
,
McDermott David
(Division of Medical Oncology, Beth Israel Deaconess Medical Center, Dana-Farber/Harvard Cancer Center, Boston, MA, USA)
,
Plimack Elizabeth R.
(Department of Hematology and Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA)
,
Barthelemy Philippe
(Medical Oncology, Institut de Cancerologie Strasbourg Europe, Strasbourg, France)
,
Porta Camillo
(University of Pavia, Pavia, Italy)
,
Powles Thomas
(Department of Urology, Barts Cancer Institute, Queen Mary University of London, Royal Free NHS Trust, London, UK)
,
Donskov Frede
(Department of Oncology, Aarhus University Hospital, Aarhus, Denmark)
,
George Saby
(Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA)
,
Kollmannsberger Christian K.
(Department of Medicine, British Columbia Cancer Agency, Vancouver, Canada)
,
Gurney Howard
(Department of Medical Oncology, Westmead Hospital and Macquarie University, Sydney, Australia)
,
Grimm Marc-Oliver
(Department of Urology, Jena University Hospital, Jena, Germany)
,
Tomita Yoshihiko
(Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan)
,
Castellano Daniel
(Medical Oncology Service, Hospital Universitario 12 de Octubre, Madrid, Spain)
,
Rini Brian I.
(Division of Hematology Oncology, Vanderbilt University Medical Center, Nashville, TN, USA)
,
Choueiri Toni K.
(Department of Medical Oncology, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA)
,
Leung David
(Department of Imaging, Bristol Myers Squibb, Princeton, NJ, USA)
,
Saggi Shruti Shally
(Department of Clinical Trials, Bristol Myers Squibb, Princeton, NJ, USA)
,
Lee Chung-Wei
(Department of Clinical Trials, Bristol Myers Squibb, Princeton, NJ, USA)
,
McHenry M. Brent
(Department of Biostatistics, Bristol Myers Squibb, Princeton, NJ, USA)
,
Motzer Robert J.
(Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA)
資料名:
European Urology
(European Urology)
巻:
81
号:
3
ページ:
266-271
発行年:
2022年
JST資料番号:
A0910B
ISSN:
0302-2838
CODEN:
EUURAV
資料種別:
逐次刊行物 (A)
記事区分:
短報
発行国:
オランダ (NLD)
言語:
英語 (EN)